UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by ABLE Financial Group LLC

ABLE Financial Group LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 121.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 4,121 shares of the healthcare conglomerate's stock after purchasing an additional 2,259 shares during the period. ABLE Financial Group LLC's holdings in UnitedHealth Group were worth $2,084,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in UnitedHealth Group during the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at about $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter valued at $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $30,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. JPMorgan Chase & Co. lowered their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. Raymond James cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Robert W. Baird decreased their price objective on UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Wolfe Research cut their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Finally, Truist Financial reissued a "buy" rating and issued a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $441.87.

UnitedHealth Group Stock Down 0.3%

Shares of UNH traded down $1.04 during trading hours on Thursday, hitting $297.07. The company had a trading volume of 10,351,888 shares, compared to its average volume of 6,724,129. The company has a market capitalization of $269.49 billion, a PE ratio of 19.14, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company's fifty day moving average price is $439.50 and its two-hundred day moving average price is $498.65. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same period in the prior year, the firm posted $6.91 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the company's stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.